Sensus Healthcare, Inc. is a medical device company It specializes in the treatment of non-melanoma skin cancers and other skin conditions, such as keloids, with superficial radiation therapy. The company's portfolio of treatment devices consists of the SRT-100(TM) and SRT-100 Vision(TM). Sensus Healthcare, Inc. is headquartered in Boca Raton, Florida.
| Revenue (Most Recent Fiscal Year) | $41.81M |
| Net Income (Most Recent Fiscal Year) | $6.65M |
| PE Ratio (Current Year Earnings Estimate) | 16.63 |
| PE Ratio (Trailing 12 Months) | 11.85 |
| PEG Ratio (Long Term Growth Estimate) | -- |
| Price to Sales Ratio (Trailing 12 Months) | 1.87 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 1.39 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | 10.97 |
| Pre-Tax Margin (Trailing 12 Months) | 21.58% |
| Net Margin (Trailing 12 Months) | 15.90% |
| Return on Equity (Trailing 12 Months) | 12.42% |
| Return on Assets (Trailing 12 Months) | 11.20% |
| Current Ratio (Most Recent Fiscal Quarter) | 9.64 |
| Quick Ratio (Most Recent Fiscal Quarter) | 7.36 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 0.00 |
| Inventory Turnover (Trailing 12 Months) | 1.13 |
| Book Value per Share (Most Recent Fiscal Quarter) | $3.41 |
| Earnings per Share (Most Recent Fiscal Quarter) | $0.09 |
| Earnings per Share (Most Recent Fiscal Year) | $0.41 |
| Diluted Earnings per Share (Trailing 12 Months) | $0.40 |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Medical Devices |
| Common Shares Outstanding | 16.50M |
| Free Float | 14.94M |
| Market Capitalization | $78.19M |
| Average Volume (Last 20 Days) | 0.11M |
| Beta (Past 60 Months) | 1.11 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 9.40% |
| Percentage Held By Institutions (Latest 13F Reports) | 25.30% |
| Annual Dividend (Based on Last Quarter) | $0.00 |
| Dividend Yield (Based on Last Quarter) | 0.00% |